Old Web
English
Sign In
Acemap
>
authorDetail
>
R.F. Hoedemaeker
R.F. Hoedemaeker
Medicine
non muscle invasive
Bladder cancer
bcg failure
Oncology
4
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Definitions of BCG-failure (EAU) vs BCG-unresponsive (FDA) in high-risk non-muscle invasive bladder cancer: A comparison of patient outcome
2020
F.C. De Jong
R.F. Hoedemaeker
V. Kvikstad
J.T.M. Mensink
E. R. Boeve
D.K.E. van der Schoot
Joost L. Boormans
Ellen C. Zwarthoff
Tahlita C.M. Zuiverloon
Show All
Source
Cite
Save
Citations (1)
Pathological T1 substaging corresponds with BCG-failure and improves the current EAU risk stratification for non-muscle invasive bladder cancer patients
2020
F.C. De Jong
R.F. Hoedemaeker
V. Kvikstad
J.T.M. Mensink
E. R. Boeve
D.K.E. van der Schoot
Joost L. Boormans
Ellen C. Zwarthoff
Tahlita C.M. Zuiverloon
Show All
Source
Cite
Save
Citations (0)
PD-L1 expression does not predict BCG-failure in a large cohort of high-risk non-muscle invasive bladder cancer patients
2020
F.C. De Jong
R.F. Hoedemaeker
A.M. van der Made
V. Kvikstad
T.P.P. van den Bosch
E. R. Boeve
D.K.E. van der Schoot
Joost L. Boormans
Ellen C. Zwarthoff
Tahlita C.M. Zuiverloon
Show All
Source
Cite
Save
Citations (0)
1